Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AI025914-04S2
Application #
3546935
Study Section
Special Emphasis Panel (SRC (03))
Project Start
1987-09-30
Project End
1992-05-31
Budget Start
1991-09-01
Budget End
1992-05-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Stosor, Valentina; Palella Jr, Frank J; Berzins, Baiba et al. (2005) Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clin Infect Dis 41:1671-4
Kim, H S; Raskova, J; Degiannis, D et al. (1994) Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells. Clin Exp Immunol 96:508-12
Lai, D; Zhu, X; Pestka, S (1993) A simple and efficient method for site-directed mutagenesis with double-stranded plasmid DNA. Nucleic Acids Res 21:3977-80
Jung, V; Pestka, S B; Pestka, S (1993) Cloning of polymerase chain reaction-generated DNA containing terminal restriction endonuclease recognition sites. Methods Enzymol 218:357-62
Hornung, N; Raskova, J; Raska Jr, K et al. (1993) Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin. Transplantation 56:985-90
Mikhail, N; Raska Jr, K; Raskova, J et al. (1993) Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC. Immunopharmacology 25:29-36
Fitzgibbon, J E; Farnham, A E; Sperber, S J et al. (1993) Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs. J Virol 67:7271-5
Fitzgibbon, J E; Mazar, S; Dubin, D T (1993) A new type of G-->A hypermutation affecting human immunodeficiency virus. AIDS Res Hum Retroviruses 9:833-8
Fitzgibbon, J E; Howell, R M; Haberzettl, C A et al. (1992) Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. Antimicrob Agents Chemother 36:153-7
Soh, J; Pestka, S (1992) Hybrid selection of mRNA with biotinylated DNA. Methods Enzymol 216:186-96

Showing the most recent 10 out of 31 publications